- Home
- INZY vs MED Comparison
INZY vs MED Comparison
Compare INZY & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- MED
- Stock Information
- Founded
- INZY 2015
- MED 1980
- Country
- INZY United States
- MED United States
- Employees
- INZY N/A
- MED N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- INZY Health Care
- MED Consumer Staples
- Exchange
- INZY Nasdaq
- MED Nasdaq
- Market Cap
- INZY 188.2M
- MED 187.3M
- IPO Year
- INZY 2020
- MED N/A
- Fundamental
- Price
- INZY $1.26
- MED $15.38
- Analyst Decision
- INZY Strong Buy
- MED Hold
- Analyst Count
- INZY 8
- MED 1
- Target Price
- INZY $17.75
- MED $17.00
- AVG Volume (30 Days)
- INZY 829.2K
- MED 241.7K
- Earning Date
- INZY 03-11-2025
- MED 02-18-2025
- Dividend Yield
- INZY N/A
- MED N/A
- EPS Growth
- INZY N/A
- MED N/A
- EPS
- INZY N/A
- MED 0.67
- Revenue
- INZY N/A
- MED $674,475,000.00
- Revenue This Year
- INZY N/A
- MED N/A
- Revenue Next Year
- INZY N/A
- MED N/A
- P/E Ratio
- INZY N/A
- MED $23.01
- Revenue Growth
- INZY N/A
- MED N/A
- 52 Week Low
- INZY $1.29
- MED $14.94
- 52 Week High
- INZY $7.80
- MED $57.41
- Technical
- Relative Strength Index (RSI)
- INZY 19.59
- MED 34.19
- Support Level
- INZY $1.32
- MED $14.94
- Resistance Level
- INZY $1.44
- MED $15.93
- Average True Range (ATR)
- INZY 0.26
- MED 0.79
- MACD
- INZY -0.12
- MED -0.05
- Stochastic Oscillator
- INZY 0.53
- MED 10.41
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.